Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Lipid Research|June 18, 2005
Control of ACAT2 liver expression by HNF1Camilla Pramfalk, Matthew A Davis, Mats Eriksson, et al.
Journal of Lipid Research|January 31, 2014
TG-interacting factor 1 acts as a transcriptional repressor of sterol O-acyltransferase 2Camilla Pramfalk, Tiffany A Melhuish, David Wotton, et al.
Drug and Alcohol Dependence|January 24, 2026
Randomized studies assessing the effect of flavor on pharmacokinetic and subjective parameters for dry and moist nicotine pouchesMikael Staaf, Anna E Masser, Camilla Pramfalk, et al.
The Journal of Clinical Endocrinology and Metabolism|September 29, 2015
Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in MenCamilla Pramfalk, Michael Pavlides, Rajarshi Banerjee, et al.
BMC Cell Biology|January 27, 2004
Insulin receptor activation and down-regulation by cationic lipid transfection reagentsCamilla Pramfalk, Johanna Lanner, Monica Andersson, et al.
BMJ Open Diabetes Research & Care|March 20, 2020
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolismCharlotte J Green, Camilla Pramfalk, Catriona A Charlton, et al.
Journal of Lipid Research|May 13, 2010
HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liverCamilla Pramfalk, Zhao-Yan Jiang, Qu Cai, et al.
The American Journal of Clinical Nutrition|February 6, 2019
Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markersFredrik Rosqvist, Catriona A McNeil, Camilla Pramfalk, et al.
Pageof 3